These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8871002

  • 1. Long-term survival and symptom palliation in small primary bronchial carcinomas following treatment with intraluminal radiotherapy alone.
    Gollins SW, Burt PA, Barber PV, Stout R.
    Clin Oncol (R Coll Radiol); 1996; 8(4):239-46. PubMed ID: 8871002
    [Abstract] [Full Text] [Related]

  • 2. High dose rate intraluminal radiotherapy for carcinoma of the bronchus: outcome of treatment of 406 patients.
    Gollins SW, Burt PA, Barber PV, Stout R.
    Radiother Oncol; 1994 Oct; 33(1):31-40. PubMed ID: 7533304
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of endobronchial metastases with intraluminal radiotherapy.
    Quantrill SJ, Burt PA, Barber PV, Stout R.
    Respir Med; 2000 Apr; 94(4):369-72. PubMed ID: 10845436
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
    Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S.
    Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):127-33. PubMed ID: 12007950
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
    Micke O, Prott FJ, Schäfer U, Wagner W, Pötter R, Willich N.
    Strahlenther Onkol; 1995 Oct 01; 171(10):554-9. PubMed ID: 8571174
    [Abstract] [Full Text] [Related]

  • 12. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
    Chang LF, Horvath J, Peyton W, Ling SS.
    Int J Radiat Oncol Biol Phys; 1994 Feb 01; 28(3):589-96. PubMed ID: 7509330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):149-54. PubMed ID: 9422571
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.
    Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, Chang TC, Fujita K, Oita M, Miyasaka K, Nishimura M, Dosaka-Akita H.
    Int J Radiat Oncol Biol Phys; 2003 May 01; 56(1):126-35. PubMed ID: 12694831
    [Abstract] [Full Text] [Related]

  • 18. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
    Gustafson G, Vicini F, Freedman L, Johnston E, Edmundson G, Sherman S, Pursel S, Komic M, Chen P, Borrego JC.
    Cancer; 1995 May 01; 75(9):2345-50. PubMed ID: 7712446
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.